431050 Sigma-AldrichInSolution™ Leptomycin B, Streptomyces sp. - CAS 87081-35-4 - Calbiochem
InSolution™ Leptomycin B, Streptomyces sp., CAS 87081-35-4, is a 20 µg/ml solution in ethanol. An antifungal agent that blocks nuclear export by impairing the function of nuclear export factor CRM1.
More>> InSolution™ Leptomycin B, Streptomyces sp., CAS 87081-35-4, is a 20 µg/ml solution in ethanol. An antifungal agent that blocks nuclear export by impairing the function of nuclear export factor CRM1. Less<<Synonyms: LMB, Chromosome Region Maintenance 1 Protein Inhibitor I, CRM1 Inhibitor I, Exportin 1 Inhibitor I, XPO1 Inhibitor I
Recommended Products
Overview
Replacement Information |
---|
Key Spec Table
CAS # | Empirical Formula |
---|---|
87081-35-4 | C₃₃H₄₈O₆ |
Description | |
---|---|
Overview | An antifungal antibiotic that acts as an inhibitor of nuclear export because of its ability to interact with and impair the function of the nuclear export factor CRM1. It is about twice as potent as Leptomycin A (Cat. No. 431051) in inhibiting nucleocytoplasmic translocation of Rev, blocks the Rev-dependent export of mRNA into cytoplasm, and suppresses HIV-1 replication in primary human monocytes (IC50 = 600 pM). In addition, LMB effectively induces the accumulation of p53 in the nucleus of normal fibroblasts as well as protects p53 from Mdm2-mediated ubiquitination and degradation. |
Caution! Product contains volatile liquid. Keep product cold at all times. | |
Catalogue Number | 431050 |
Brand Family | Calbiochem® |
Synonyms | LMB, Chromosome Region Maintenance 1 Protein Inhibitor I, CRM1 Inhibitor I, Exportin 1 Inhibitor I, XPO1 Inhibitor I |
Product Information | |
---|---|
CAS number | 87081-35-4 |
ATP Competitive | N |
Form | Liquid |
Formulation | Supplied at 20 µg/ml (5 µg in 250 µl) in absolute ethanol |
Hill Formula | C₃₃H₄₈O₆ |
Chemical formula | C₃₃H₄₈O₆ |
Reversible | N |
Structure formula Image | |
Quality Level | MQ100 |
Biological Information | |
---|---|
Primary Target | HIV-1 replication in primary human monocytes |
Primary Target IC<sub>50</sub> | 600 pM in suppressing HIV-1 replication in primary human monocytes |
Purity | ≥95% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | N |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalogue Number | GTIN |
431050 | 0 |
Documentation
Required Licenses
Title |
---|
PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD |
InSolution™ Leptomycin B, Streptomyces sp. - CAS 87081-35-4 - Calbiochem SDS
Title |
---|
InSolution™ Leptomycin B, Streptomyces sp. - CAS 87081-35-4 - Calbiochem Certificates of Analysis
Title | Lot Number |
---|---|
431050 |
References
Reference overview |
---|
Kau, T.R., and Silver, P.A. 2003. Drug Discov. Today 8, 78. Menendez, S., et al. 2003. Br. J. Cancer 88, 636. Xirodimas, D.P., et al. 2001. Exp. Cell Res. 270, 66. Kudo, N., et al. 1999. Proc. Natl. Acad. Sci. USA 96, 9112. Lain, S., et al. 1999. Exp. Cell Res. 248, 457. Wolff, B., et al. 1997. Chem. Biol. 4, 139. Yoshida, M., et al. 1990. Exp. Cell Res. 187, 150. Komiyama, K., et al. 1985. J. Antibiot. 38, 427. |